HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.
作者信息
Alexander B, De Vries A, Addelson E
机构信息
Medical Research Laboratory, Beth Israel Hospital, Boston.
出版信息
J Clin Invest. 1949 Jan;28(1):24-31. doi: 10.1172/JCI102048.
Abstract
摘要
相似文献
1
HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.
J Clin Invest. 1949 Jan;28(1):24-31. doi: 10.1172/JCI102048.
2
3
The assay and properties of labile factor (factor V).
J Clin Pathol. 1960 Nov;13(6):457-62. doi: 10.1136/jcp.13.6.457.
4
The pathogenesis of hemophilia; an experimental analysis of the anticephalin hypothesis in hemophilic dogs.
J Exp Med. 1957 Aug 1;106(2):273-92. doi: 10.1084/jem.106.2.273.
5
Human prothrombin metabolism in normal man and in hypocoagulable subjects.
J Clin Invest. 1969 Jul;48(7):1292-8. doi: 10.1172/JCI106095.
6
Activation of purified prothrombin with hemophilic plasma.
Am J Clin Pathol. 1953 Sep;23(9):875-80. doi: 10.1093/ajcp/23.9.875.
7
Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
Thromb Diath Haemorrh. 1959 Sep 1;3:588-92.
8
THERAPY FOR THE HEMOPHILIC PATIENT.
Mich Med. 1964 Dec;63:866-9.
9
Accelerator factors in hemophilic blood.
Am J Physiol. 1950 Oct;163(1):148-52. doi: 10.1152/ajplegacy.1950.163.1.148.
10
[Prothrombin level in hemophilic blood and in hemophilic-like blood after the addition in vitro of fresh normal blood].
Boll Soc Ital Biol Sper. 1952 Dec;28(12):1890-2.
引用本文的文献
1
The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.
J Clin Invest. 1950 Jul;29(7):881-95. doi: 10.1172/JCI102322.
2
Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.
J Clin Invest. 1951 Jun;30(6):596-608. doi: 10.1172/JCI102477.
3
The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.
J Clin Invest. 1951 Mar;30(3):252-62. doi: 10.1172/JCI102439.
4
The assay and properties of labile factor (factor V).
J Clin Pathol. 1960 Nov;13(6):457-62. doi: 10.1136/jcp.13.6.457.
5
Prothrombin time. Determination by a whole blood micro-method for control of anticoagulant therapy.
Calif Med. 1961 Jul;95(1):24-9.
Zotero 插件